Item 2.02 Results of Operations and Financial Condition

On August 13, 2021, Outlook Therapeutics, Inc. (the "Company") issued a press release announcing its financial results for its third fiscal quarter ended June 30, 2021. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained in this Item 2.02 and in the accompanying Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits






(d) Exhibits.



Exhibit No.   Description

99.1 Press Release dated August 13, 2021.

© Edgar Online, source Glimpses